GDF2 and pulmonary arterial hypertension: In PAH patients without GDF2 mutations, a few individuals have low BMP9 levels but detectable pBMP10 and vice‐versa, so heterodimers may not account for all circulating BMP9 and BMP10 (Hodgson et al., 2019).